Monogram Technologies Inc

Análisis de la acción Monogram Technologies Inc (MGRM)

$6.000

-0.108 (-1.80%)Al cierre

Loading chart…
High
6.425
Open
6.100
VWAP
6.10
Vol
1.78M
Mkt Cap
65.56M
Low
5.870
Amount
10.84M
EV/EBITDA, TTM
-3.28

Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.

Métricas de valoración

The current forward P/E ratio for Monogram Technologies Inc (MGRM) is -3.30, compared to its 5-year average forward P/E of -5.34.

Forward P/E

Fair
5Y Average P/E
-5.34
Current P/E
-3.30
Sobrevalorada
0.02
Infravalorada
-10.70

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-5.46
Current EV/EBITDA
-3.28
Sobrevalorada
1.03
Infravalorada
-11.95

Forward P/S

Fair
5Y Average P/S
24.22
Current P/S
14.06
Sobrevalorada
57.45
Infravalorada
-9.00

Alphio AI Price Scenarios for MGRM

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%MGRM

$6.90

Precio del escenario

B

Base

Base · 50%MGRM

$6.18

Precio del escenario

B

Bear

Bear · 25%MGRM

$5.93

Precio del escenario

Cronología de eventos

2025-10-07 (ET)

09:06:58

Zimmer Biomet finalizes purchase of Monogram Technologies

2025-07-29 (ET)

09:34:04

Monogram completes fully autonomous saw-based robotic knee replacement procedure

2025-07-14 (ET)

07:39:29

Zimmer Biomet to acquire Monogram for $4.04 per share in cash upfront

07:32:34

Zimmer Biomet to acquire Monogram Orthopaedics for $177M

2025-07-08 (ET)

08:53:14

Monogram Orthopaedics announces conversion of Series D Preferred Stock

Noticias

MGRM FAQ — answered by Alphio AI

Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis